Meritage Portfolio Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.01M | Buy |
+11,455
| New | +$6.01M | 0.38% | 68 |
|
|
2024
Q2 | – | Sell |
-595
| Closed | -$573K | – | 346 |
|
|
2024
Q1 | $573K | Hold |
595
| – | – | 0.04% | 237 |
|
|
2023
Q4 | $523K | Hold |
595
| – | – | 0.03% | 246 |
|
|
2023
Q3 | $490K | Hold |
595
| – | – | 0.04% | 240 |
|
|
2023
Q2 | $428K | Hold |
595
| – | – | 0.03% | 256 |
|
|
2023
Q1 | $489K | Hold |
595
| – | – | 0.04% | 212 |
|
|
2022
Q4 | $429K | Buy |
595
+8
| +1% | +$5.77K | 0.03% | 220 |
|
|
2022
Q3 | $404K | Buy |
+587
| New | +$404K | 0.03% | 225 |
|
|
2022
Q2 | – | Sell |
-16,733
| Closed | -$11.7M | – | 339 |
|
|
2022
Q1 | $11.7M | Buy |
+16,733
| New | +$11.7M | 0.72% | 25 |
|
|
2020
Q3 | – | Sell |
-10,082
| Closed | -$6.29M | – | 239 |
|
|
2020
Q2 | $6.29M | Buy |
+10,082
| New | +$6.29M | 0.6% | 41 |
|